Enzymolysis refining method of heparin sodium

By combining modified protease with polyacrylamide gel, combined with ethylenediaminetetraacetic acid and hydrogen peroxide oxidation method, the problems of low product yield, titer and purity in the traditional heparin sodium refining process are solved, and high efficiency is achieved Enzymatic refining of sodium heparin reduces production costs.

CN119039480AInactive Publication Date: 2024-11-29ZAOZHUANG SAINUOKANG BIOCHEMICAL CO LTD

Patent Information

Application Number
CN202411549164.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-01
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The traditional heparin sodium refining process has problems such as low product yield, low titer, low purity and high production costs, and it is difficult to effectively remove protein impurities in heparin sodium.

Method used

Modified protease is used to physically adsorb in polyacrylamide gel, combined with ethylenediaminetetraacetic acid and hydrogen peroxide oxidation method, and the protein impurities in sodium heparin were removed and the product purity and yield were improved.

Benefits of technology

It improves the stability and activity of enzymes, extends the service life of enzymes, reduces production costs, improves product quality and yield, and facilitates the recycling and reuse of enzymes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

The invention relates to the technical field of heparin sodium enzymolysis, in particular to a heparin sodium enzymolysis refining method. Comprising the following steps: S1.1, weighing the following raw materials in parts by weight: 0.5 to 1 part of modified protease, 45 to 50 parts of crude heparin sodium, 0.1 to 0.3 part of ethylenediamine tetraacetic acid, 0.05 to 0.1 part of ascorbic acid, 1 to 5 parts of sodium chloride, 3 to 5 parts of hydrogen peroxide and 120 to 180 parts of absolute ethyl alcohol; wherein the modified protease is prepared from trypsin and polyacrylamide gel according to the mass ratio of 1: (1-3) through physical adsorption; s1.2, dissolving the crude product heparin sodium; s1.3, carrying out enzymolysis on the crude product heparin sodium; s1.4, oxidizing the crude heparin sodium, and S1.5, precipitating to obtain refined heparin sodium, modified trypsin is adopted, and the trypsin is physically adsorbed in polyacrylamide gel, so that the stability of the trypsin is improved, the improvement of the product quality and yield is facilitated, and the heparin sodium is convenient to recycle and reuse.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of heparin sodium enzymolysis, in particular to a method for refining heparin sodium enzymolysis. Background Art

[0002] Heparin, also known as heparin sodium, is a mucopolysaccharide produced by mast cells of animal connective tissue. It is widely distributed in mammalian tissues, such as liver, lung and intestinal mucosa, heart, spleen, kidney, thymus, placenta, muscle and blood. Due to its strong anticoagulant effect, heparin sodium is the first choice for preventing and treating thromboembolic diseases such as deep vein thrombosis. Although it has a history of more than 80 years in clinical use, there is no product that can completely replace it so far. Therefore, it is still one of the most important anticoagulant and antithrombotic biochemical drugs at present, and it is also one of my country's major export drugs. With the deepening of research, people have found that heparin sodium not only has the effects of anticoagulation, antithrombosis and regulating blood lipids, but also has multiple biological functions such as anti-inflammatory, anti-allergic, anti-viral and anti-cancer.

[0003] Heparin, like most mucopolysaccharides, exists in the form of heparin sodium-protein complex in animals. Due to incomplete dissociation of heparin sodium during the extraction process, a certain amount of protein remains in the crude heparin sodium, which needs to be further refined before it can be used clinically. However, the traditional refining process of heparin sodium is mainly based on oxidation method, but there are problems such as low yield, low potency, low purity and high production cost of the refined product. In view of this, we propose a method for enzymatic refining of heparin sodium. Summary of the invention

[0004] The object of the present invention is to provide a method for enzymatically purifying heparin sodium to solve the problems raised in the above-mentioned background technology.

[0005] To achieve the above object, the present invention provides a method for enzymatically purifying heparin sodium, comprising the following steps: S1.1, weigh the following raw materials in parts by weight: 0.5-1 parts by weight of modified protease, 45-50 parts by weight of crude heparin sodium, 0.1-0.3 parts by weight of ethylenediaminetetraacetic acid, 0.05-0.1 parts by weight of ascorbic acid, 1-5 parts by weight of sodium chloride, 3-5 parts by weight of hydrogen peroxide, and 120-180 parts by weight of anhydrous ethanol; The modified protease is prepared by physical adsorption of trypsin and polyacrylamide gel at a mass ratio of 1:1 to 3; S1.2, grind and sieve the crude heparin sodium, then dissolve it in a 1-5% NaCl solution, heat it to 30-50°C, adjust the pH value to 8-9, and keep it warm for 30-50 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 45-55°C, enzymolysis time 2-3h, after the reaction is completed, heat the mixed solution to 80-100°C, keep warm for 20-30min, and cool naturally to room temperature; S1.4, add hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 20-25°C for 10-12 hours, and then filter and separate to obtain an oxidized solution; S1.5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 3-5 hours, and centrifuge it at 3000-5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

[0006] Trypsin is used to specifically cut peptide bonds in protein molecules, converting large molecular proteins into small molecular peptides or amino acids, which are used to remove insoluble impurities in crude heparin sodium, degrade impurity proteins in heparin sodium into small molecular peptides, and dissociate heparin sodium molecules from heparin sodium-protein complexes. The enzyme protein and the degraded protein fragments, i.e., small molecular peptides, are then removed by hydrogen peroxide oxidation to obtain fine heparin sodium. However, trypsin is unstable at high temperatures or during long-term treatment, and then inactivated. Moreover, free trypsin is difficult to recover and reuse after the reaction, resulting in increased costs. Therefore, polyacrylamide gel is used to physically adsorb trypsin, which improves the stability of trypsin and allows it to remain active over a wider temperature range and for a longer period of time. At the same time, the modified trypsin can be easily separated from the reaction mixture by simple filtration or centrifugation steps, which is convenient for recovery and reuse, thereby reducing production costs.

[0007] EDTA is a chelating agent that can bind to metal ions, especially calcium and magnesium ions. During the purification of sodium heparin, EDTA can chelate metal ions in the solution to prevent them from interacting with proteases or other proteins, thereby avoiding the effects of metal ions on enzyme activity or nonspecific precipitation of proteins. It can ensure that the activity of proteases is not interfered by metal ions and also helps to remove some metal ion pollutants. Ascorbic acid is an antioxidant that can protect sodium heparin and enzymes from oxidative damage. During the purification of sodium heparin, ascorbic acid can scavenge free radicals and other oxidants to maintain the stability and activity of sodium heparin and enzymes.

[0008] Preferably, in S1.2, the diameter of the powder of the crude heparin sodium after crushing and sieving is less than 30 mesh.

[0009] Preferably, in S1.4, the mass fraction of the hydrogen peroxide solution is 30-50%, and the added amount is 0.1-0.3% of the volume of the mixed solution.

[0010] Preferably, in S1.5, the volume ratio of the oxidizing liquid to anhydrous ethanol is 1:1-3.

[0011] Preferably, the steps of preparing the modified protease are specifically as follows: S2.1. Mix the acrylamide solution and N,N'-methylenebisacrylamide solution evenly, add Tris-HCl buffer, add ammonium persulfate initiator to the mixed solution, quickly add 2-3 drops of tetramethylethylenediamine, pour the mixed solution into a mold, and cover the top with a glass plate to ensure a smooth surface. Polymerize at room temperature for 12-24 hours, cut the polymerized polyacrylamide gel into small particles, wash with buffer 1-3 times to remove unbound substances, and obtain small particles of polyacrylamide gel; S2.2. Dissolve trypsin in Tris-HCl buffer, mix the trypsin solution with small granular polyacrylamide gel, stir with a magnetic stirrer at a speed of 100-200 rpm / min, and adsorb for 1-4 hours. Use a low-speed centrifuge at a centrifugal speed of about 1000-2000 rpm / min and a centrifugal time of 5-10 minutes to separate the non-adsorbed enzyme and the immobilized enzyme. Then freeze-dry and store at -20°C to -15°C to obtain a modified protease.

[0012] Acrylamide is the main polymerization monomer, N,N'-methylenebisacrylamide is used as a cross-linking agent to form a three-dimensional network structure of the polymer, ammonium persulfate is used as a chemical initiator to generate free radicals through thermal decomposition, and tetramethylethylenediamine is used as a catalyst to accelerate the free radicals generated by ammonium persulfate to initiate acrylamide polymerization.

[0013] Preferably, in S2.1, the volume ratio of the acrylamide solution to the N,N'-methylenebisacrylamide solution is 10:0.3-0.5.

[0014] Preferably, in S2.1, the mass concentration of the acrylamide solution is 8-10%, and the mass concentration of the N,N'-methylenebisacrylamide solution is 0.3-0.5%.

[0015] Preferably, in S2.1, the mass concentration of the ammonium persulfate initiator is 0.1-0.5%, and the added amount is 0.05-0.1% of the total volume of the mixed solution.

[0016] Preferably, in S2.1, the mass concentration of tetramethylethylenediamine is 0.1-0.3%.

[0017] Preferably, in S2.2, the concentration of trypsin in Tris-HCl buffer is 1-10 mg / mL.

[0018] Compared with the prior art, the present invention has the following beneficial effects: In the enzymatic hydrolysis and purification method of sodium heparin, modified trypsin is used to physically adsorb the trypsin in polyacrylamide gel, thereby improving the stability of the trypsin, being able to maintain activity in a wider temperature range, and extending the service life of the enzyme. In addition, the physical adsorption of trypsin can more easily control the activity and reaction conditions of the enzyme, and the reaction rate can be adjusted by adjusting the enzyme loading, which is easy to optimize process parameters and helps to improve product quality and yield. At the same time, the modified trypsin can be easily separated from the reaction mixture through simple filtration or centrifugation steps, which is convenient for recovery and reuse, reducing enzyme consumption and reducing production costs. DETAILED DESCRIPTION

[0019] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0020] A method for enzymatically purifying heparin sodium of the present invention comprises the following steps: S1.1, weigh the following raw materials in parts by weight: 0.5-1 parts by weight of modified protease, 45-50 parts by weight of crude heparin sodium, 0.1-0.3 parts by weight of ethylenediaminetetraacetic acid, 0.05-0.1 parts by weight of ascorbic acid, 1-5 parts by weight of sodium chloride, 3-5 parts by weight of hydrogen peroxide, and 120-180 parts by weight of anhydrous ethanol; The modified protease is prepared by physical adsorption of trypsin and polyacrylamide gel at a mass ratio of 1:1 to 3; S1.2, grind and sieve the crude heparin sodium, then dissolve it in a 1-5% NaCl solution, heat it to 30-50°C, adjust the pH value to 8-9, and keep it warm for 30-50 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 45-55°C, enzymolysis time 2-3h, after the reaction is completed, heat the mixed solution to 80-100°C, keep warm for 20-30min, and cool naturally to room temperature; S1.4, add hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 20-25°C for 10-12 hours, and then filter and separate to obtain an oxidized solution; S1.5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 3-5 hours, and centrifuge it at 3000-5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

[0021] Embodiment 1: A method for enzymatic purification of heparin sodium, comprising the following steps: S1.1, weigh the following raw materials: 0.5 g of modified protease, 50 g of crude heparin sodium, 0.1 g of ethylenediaminetetraacetic acid, 0.05 g of ascorbic acid, 5 g of sodium chloride, 3 g of hydrogen peroxide, and 120 g of anhydrous ethanol; The modified protease was prepared by physical adsorption of trypsin and polyacrylamide gel in a mass ratio of 1:1; the volume ratio of acrylamide solution to N,N'-methylenebisacrylamide solution was 10:0.5; the amount of ammonium persulfate initiator added was 0.05% of the total volume of the mixed solution; The preparation steps of the modified protease are as follows: S2.1. Evenly mix an 8% acrylamide solution and a 0.3% N,N'-methylenebisacrylamide solution, add Tris-HCl buffer, add 0.1% ammonium persulfate initiator to the mixed solution, quickly add 3 drops of 0.1% tetramethylethylenediamine, pour the mixed solution into a mold, cover the top with a glass plate to ensure a smooth surface, polymerize at room temperature for 12 hours, cut the polymerized polyacrylamide gel into small particles, wash twice with buffer to remove unbound substances, and remove the residues. S2.2, dissolving trypsin in Tris-HCl buffer, the concentration of trypsin in Tris-HCl buffer is 5 mg / mL, mixing the trypsin solution with the small granular polyacrylamide gel, stirring with a magnetic stirrer, the stirring speed is 100 rpm / min, the adsorption time is 4 hours, using a low-speed centrifuge, the centrifugal speed is about 2000 rpm / min, the centrifugal time is 5 minutes, to separate the non-adsorbed enzyme and the immobilized enzyme, and then freeze-drying and storing at -20°C to obtain a modified protease.

[0022] S1.2, grind and sieve the crude heparin sodium to obtain a powder with a diameter of less than 30 mesh, then dissolve it in a 5% NaCl solution, heat it to 50°C, adjust the pH value to 8, and keep it warm for 30 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 50°C, enzymolysis time 3h, after the reaction is completed, heat the mixed solution to 100°C, keep warm for 30min, and cool naturally to room temperature; S1.4, add 0.1% by mass of 30% hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 25°C for 12 hours, and then filter and separate to obtain an oxidized solution; S1.5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 5 hours, and centrifuge it at 5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

[0023] Embodiment 2: A method for enzymatic purification of heparin sodium, comprising the following steps: S1.1, weigh the following raw materials: 0.7 g of modified protease, 50 g of crude heparin sodium, 0.1 g of ethylenediaminetetraacetic acid, 0.05 g of ascorbic acid, 5 g of sodium chloride, 3 g of hydrogen peroxide, and 120 g of anhydrous ethanol; The modified protease was prepared by physical adsorption of trypsin and polyacrylamide gel in a mass ratio of 1:1; the volume ratio of acrylamide solution to N,N'-methylenebisacrylamide solution was 10:0.5; the amount of ammonium persulfate initiator added was 0.05% of the total volume of the mixed solution; The preparation steps of the modified protease are as follows: S2.1. Evenly mix an 8% acrylamide solution and a 0.3% N,N'-methylenebisacrylamide solution, add Tris-HCl buffer, add 0.1% ammonium persulfate initiator to the mixed solution, quickly add 3 drops of 0.1% tetramethylethylenediamine, pour the mixed solution into a mold, cover the top with a glass plate to ensure a smooth surface, polymerize at room temperature for 12 hours, cut the polymerized polyacrylamide gel into small particles, wash twice with buffer to remove unbound substances, and remove the residues. S2.2, dissolving trypsin in Tris-HCl buffer, the concentration of trypsin in Tris-HCl buffer is 5 mg / mL, mixing the trypsin solution with the small granular polyacrylamide gel, stirring with a magnetic stirrer, the stirring speed is 100 rpm / min, the adsorption time is 4 hours, using a low-speed centrifuge, the centrifugal speed is about 2000 rpm / min, the centrifugal time is 5 minutes, to separate the non-adsorbed enzyme and the immobilized enzyme, and then freeze-drying and storing at -20°C to obtain a modified protease.

[0024] S1.2, grind and sieve the crude heparin sodium to obtain a powder with a diameter of less than 30 mesh, then dissolve it in a 5% NaCl solution, heat it to 50°C, adjust the pH value to 8, and keep it warm for 30 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 50°C, enzymolysis time 3h, after the reaction is completed, heat the mixed solution to 100°C, keep warm for 30min, and cool naturally to room temperature; S1.4, add 0.1% by mass of 30% hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 25°C for 12 hours, and then filter and separate to obtain an oxidized solution; S1.5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 5 hours, and centrifuge it at 5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

[0025] Embodiment 3: A method for enzymatic purification of heparin sodium, comprising the following steps: S1.1, weigh the following raw materials: 1g modified protease, 50g crude heparin sodium, 0.1g ethylenediaminetetraacetic acid, 0.05g ascorbic acid, 5g sodium chloride, 3g hydrogen peroxide, 120g anhydrous ethanol; The modified protease was prepared by physical adsorption of trypsin and polyacrylamide gel in a mass ratio of 1:1; the volume ratio of acrylamide solution to N,N'-methylenebisacrylamide solution was 10:0.5; the amount of ammonium persulfate initiator added was 0.05% of the total volume of the mixed solution; The preparation steps of the modified protease are as follows: S2.1. Evenly mix an 8% acrylamide solution and a 0.3% N,N'-methylenebisacrylamide solution, add Tris-HCl buffer, add 0.1% ammonium persulfate initiator to the mixed solution, quickly add 3 drops of 0.1% tetramethylethylenediamine, pour the mixed solution into a mold, cover the top with a glass plate to ensure a smooth surface, polymerize at room temperature for 12 hours, cut the polymerized polyacrylamide gel into small particles, wash twice with buffer to remove unbound substances, and remove the residues. S2.2, dissolving trypsin in Tris-HCl buffer, the concentration of trypsin in Tris-HCl buffer is 5 mg / mL, mixing the trypsin solution with the small granular polyacrylamide gel, stirring with a magnetic stirrer, the stirring speed is 100 rpm / min, the adsorption time is 4 hours, using a low-speed centrifuge, the centrifugal speed is about 2000 rpm / min, the centrifugal time is 5 minutes, to separate the non-adsorbed enzyme and the immobilized enzyme, and then freeze-drying and storing at -20°C to obtain a modified protease.

[0026] S1.2, grind and sieve the crude heparin sodium to obtain a powder with a diameter of less than 30 mesh, then dissolve it in a 5% NaCl solution, heat it to 50°C, adjust the pH value to 8, and keep it warm for 30 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 50°C, enzymolysis time 3h, after the reaction is completed, heat the mixed solution to 100°C, keep warm for 30min, and cool naturally to room temperature; S1.4, add 0.1% by mass of 30% hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 25°C for 12 hours, and then filter and separate to obtain an oxidized solution; S1.5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 5 hours, and centrifuge it at 5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

[0027] Embodiment 4: A method for enzymatic purification of heparin sodium, comprising the following steps: S1.1. Weigh the following raw materials: 1 g of modified protease, 45 g of crude heparin sodium, 0.3 g of ethylenediaminetetraacetic acid, 0.1 g of ascorbic acid, 1 g of sodium chloride, 5 g of hydrogen peroxide, and 180 g of anhydrous ethanol; The modified protease was prepared by physical adsorption of trypsin and polyacrylamide gel in a mass ratio of 1:1; the volume ratio of acrylamide solution to N,N'-methylenebisacrylamide solution was 10:0.3; the amount of ammonium persulfate initiator added was 0.01% of the total volume of the mixed solution; The preparation steps of the modified protease are as follows: S2.1. Mix a 10% acrylamide solution and a 0.5% N,N'-methylenebisacrylamide solution evenly, add Tris-HCl buffer, add 0.5% ammonium persulfate initiator to the mixed solution, quickly add 3 drops of 0.3% tetramethylethylenediamine, pour the mixed solution into a mold, cover the top with a glass plate to ensure a smooth surface, polymerize at room temperature for 12 hours, cut the polymerized polyacrylamide gel into small particles, wash twice with buffer to remove unbound substances. S2.2, dissolving trypsin in Tris-HCl buffer, the concentration of trypsin in Tris-HCl buffer is 10 mg / mL, mixing the trypsin solution with the small granular polyacrylamide gel, stirring with a magnetic stirrer, the stirring speed is 100 rpm / min, the adsorption time is 4 hours, using a low-speed centrifuge, the centrifugal speed is about 2000 rpm / min, the centrifugal time is 5 minutes, to separate the non-adsorbed enzyme and the immobilized enzyme, and then freeze-drying and storing at -20°C to obtain a modified protease.

[0028] S1.2, grind and sieve the crude heparin sodium to obtain a powder with a diameter of less than 30 mesh, then dissolve it in a 1% NaCl solution, heat it to 50°C, adjust the pH value to 8, and keep it warm for 30 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 50°C, enzymolysis time 3h, after the reaction is completed, heat the mixed solution to 100°C, keep warm for 30min, and cool naturally to room temperature; S1.4, add 0.3% by mass of 50% hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 25°C for 12 hours, and then filter and separate to obtain an oxidized solution; S1.5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 5 hours, and centrifuge it at 5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

[0029] Comparative Example 1: The method of Example 3 was adopted, and trypsin was directly added without modifying the trypsin.

[0030] Comparative Example 2: The method of Example 3 was adopted, and the modified protease was prepared by using trypsin and polyacrylamide gel in a mass ratio of 1:5.

[0031] The present invention discloses a method for enzymatically purifying heparin sodium by using a modified protease, wherein the performance index inspection items and inspection standards of the method for enzymatically purifying heparin sodium are as follows: Weigh the refined heparin sodium after drying, and also weigh the crude product mass. Calculate according to the formula: finished product yield (%) = (refined product weight / crude product weight) × 100%.

[0032] The potency of heparin sodium is an important quality control indicator, which reflects the biological activity and efficacy of heparin sodium. As an anticoagulant, the potency of heparin sodium directly affects the effect and safety of its clinical application. It indicates the number of anticoagulant activity units (U) of heparin sodium per unit weight (usually per milligram). The main function of heparin sodium is anticoagulation. The higher its potency, the stronger the anticoagulant activity of heparin sodium per unit weight. The potency determination steps are as follows: the frozen sheep plasma method is used for determination. An appropriate amount of heparin sodium raw material is weighed and diluted to a potency concentration equivalent to the standard solution (8U / mL) with 0.15 mol / L NaCl solution according to the estimated potency. According to the semi-freezing point of sheep plasma, 3-5 gradients of samples and standards are respectively drawn, 1 mL of sheep plasma and 0.8 mL of 0.05 mol / L CaCl2 solution are added, and the samples are placed in a 37±0.5℃ water bath for 1 hour. The degree of coagulation of each tube is recorded. According to the sample potency = (V std ×C std × V) / (Vsam ×W sam ), V std The volume of heparin added to 1 / 2 the coagulation degree of the standard (μL); C std Concentration of standard solution (U / mL); V sam The added volume when the sample solidifies at 1 / 2 degree (μL); W sam The sample is weighed (mg); V is the total volume of the sample (mL).

[0033] Weigh heparin sodium, add a certain amount of water to dissolve it, and then quantitatively dilute it to make a solution containing 4 mg per 1 mL. Measure the absorbance at a wavelength of 260 nm using a UV-visible spectrophotometer. According to the General Chapter 0401 UV-visible spectrophotometry of the "Chinese Pharmacopoeia", the absorbance measured at a wavelength of 260 nm shall not exceed 0.10.

[0034] According to the above standards, the enzymatic purification method of heparin sodium prepared in the above Examples 1-4 and Comparative Examples 1-2 was tested, and the obtained data are shown in Table 1: Table 1 Performance data of Examples 1-4 and Comparative Examples 1-2

[0035] The above data fully show that compared with Comparative Examples 1-2, Examples 1-4 can fully show the effect of the modified protease on the yield, potency and purity of a heparin sodium enzymatic purification method.

[0036] Since the present invention adopts modified protease to prepare a method for enzymatic hydrolysis and purification of heparin sodium, the yield, potency and purity of the method for enzymatic hydrolysis and purification of heparin sodium are effectively improved by the modified protease, as follows: It can be seen from Examples 1-3 that as the amount of modified trypsin increases, the performance of a method for enzymatic purification of sodium heparin first increases and then decreases. This is because as the concentration of the enzyme increases, more active sites can participate in the catalytic reaction, thereby improving the degradation efficiency of the enzyme on sodium heparin. The modified trypsin can not only help degrade the macromolecular fragments in sodium heparin, but also degrade the protein impurities associated with sodium heparin, thereby improving the purity of the final product. However, after exceeding a certain threshold, excessive enzymes will cause excessive degradation or form inhibitory complexes, so they need to be added in an appropriate amount.

[0037] It can be seen from Examples 3 and 4 that as the content of other components continues to increase, the performance of a method for enzymatic hydrolysis and purification of heparin sodium does not change significantly. This is because the concentration of other auxiliary components reaches a certain level, and a small change in dosage has a limited effect on the reaction result. The factors that determine the performance of fine heparin sodium are not these auxiliary components, so the product performance of the method for enzymatic hydrolysis and purification of heparin sodium does not change significantly.

[0038] According to the above test experiments, the enzymatic hydrolysis and purification method of heparin sodium prepared according to Example 3 has the best performance, so Example 3 is taken as the best example; By comparing Example 3 with Comparative Examples 1-2, it can be seen that: Comparative Example 1 directly adds trypsin without modifying the trypsin, and the enzymatic purification method of heparin sodium is poor. This is because the unmodified trypsin is not as stable as the modified trypsin, especially in the long reaction process, it is easy to be inactivated, while the modified trypsin is generally more stable, can better withstand these conditions, and maintain a higher activity. In addition, the activity of the modified trypsin is easier to control the reaction rate, which helps to improve the quality and consistency of the product. Therefore, the performance of the refined heparin sodium is poor.

[0039] In comparative example 2, the modified protease was prepared by trypsin and polyacrylamide gel in a mass ratio of 1:5, which is a poor method for enzymatic purification of sodium heparin. This is because when the mass ratio of trypsin to polyacrylamide gel is 1:5, the loading amount of trypsin is insufficient, which is insufficient to provide sufficient enzyme activity for efficient enzymatic reaction, and the reaction rate is slowed down. At the same time, too low enzyme loading cannot effectively remove protein impurities, so the product performance is poor.

[0040] In summary, by modifying the protease and physically adsorbing trypsin into the polyacrylamide gel, the stability of the enzyme is improved, the activity is maintained for a longer time, the service life of the enzyme is extended, and the reaction rate can be adjusted by adjusting the enzyme loading amount, which helps to improve product quality and output, and is easy to recycle and reuse, thereby reducing production costs.

[0041] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments, and the above embodiments and descriptions are only preferred examples of the present invention, and are not intended to limit the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, and these changes and improvements all fall within the scope of the present invention to be protected.

Claims

1. A method for purifying heparin sodium by enzymatic hydrolysis, characterized in that: The steps include: S1.1, weigh the following raw materials in parts by weight: 0.5-1 parts by weight of modified protease, 45-50 parts by weight of crude heparin sodium, 0.1-0.3 parts by weight of ethylenediaminetetraacetic acid, 0.05-0.1 parts by weight of ascorbic acid, 1-5 parts by weight of sodium chloride, 3-5 parts by weight of hydrogen peroxide, and 120-180 parts by weight of anhydrous ethanol; The modified protease is prepared by physical adsorption of trypsin and polyacrylamide gel at a mass ratio of 1:1 to 3; S1.2, grind and sieve the crude heparin sodium, then dissolve it in a 1-5% NaCl solution, heat it to 30-50°C, adjust the pH value to 8-9, and keep it warm for 30-50 minutes to obtain a crude solution; S1.3, add modified protease, ethylenediaminetetraacetic acid and ascorbic acid to the crude solution in sequence, heat to 45-55°C, enzymolysis time 2-3h, after the reaction is completed, heat the mixed solution to 80-100°C, keep warm for 20-30min, and cool naturally to room temperature; S1.4, add hydrogen peroxide solution to the mixed solution, allow to stand for oxidation treatment at 20-25°C for 10-12 hours, and then filter and separate to obtain an oxidized solution; S1.

5. Add anhydrous ethanol to the oxidation solution, stir it with a stirrer, let it stand for 3-5 hours, and centrifuge it at 3000-5000r / min in a horizontal centrifuge to obtain the lower layer of precipitate. After vacuum drying, you can get the fine heparin sodium.

2. The method for enzymatic purification of heparin sodium according to claim 1, characterized in that: In S1.2, the diameter of the powder of the crude heparin sodium after crushing and sieving is less than 30 meshes.

3. The method for enzymatic purification of heparin sodium according to claim 1, characterized in that: In S1.4, the mass fraction of the hydrogen peroxide solution is 30-50%, and the added amount is 0.1-0.3% of the volume of the mixed solution.

4. The method for enzymatic purification of heparin sodium according to claim 1, characterized in that: In the above S1.5, the volume ratio of the oxidizing liquid to anhydrous ethanol is 1:1-3.

5. The method for enzymatic purification of heparin sodium according to claim 1, characterized in that: The steps of preparing the modified protease are specifically as follows: S2.

1. Mix the acrylamide solution and N,N'-methylenebisacrylamide solution evenly, add Tris-HCl buffer, add ammonium persulfate initiator to the mixed solution, quickly add 2-3 drops of tetramethylethylenediamine, pour the mixed solution into a mold, and cover the top with a glass plate to ensure a smooth surface. Polymerize at room temperature for 12-24 hours, cut the polymerized polyacrylamide gel into small particles, wash with buffer 1-3 times to remove unbound substances, and obtain small particles of polyacrylamide gel; S2.

2. Dissolve trypsin in Tris-HCl buffer, mix the trypsin solution with small granular polyacrylamide gel, stir with a magnetic stirrer at a speed of 100-200 rpm / min, and adsorb for 1-4 hours. Use a low-speed centrifuge at a centrifugal speed of about 1000-2000 rpm / min and a centrifugal time of 5-10 minutes to separate the non-adsorbed enzyme and the immobilized enzyme. Then freeze-dry and store at -20°C to -15°C to obtain a modified protease.

6. The method for purifying heparin sodium by enzymatic hydrolysis according to claim 4, characterized in that: In the S2.1, the volume ratio of the acrylamide solution to the N,N'-methylenebisacrylamide solution is 10:0.3-0.

5.

7. The method for purifying heparin sodium by enzymatic hydrolysis according to claim 4, characterized in that: In S2.1, the mass concentration of the acrylamide solution is 8-10%, and the mass concentration of the N,N'-methylenebisacrylamide solution is 0.3-0.5%.

8. The method for purifying heparin sodium by enzymatic hydrolysis according to claim 4, characterized in that: In the S2.1, the mass concentration of the ammonium persulfate initiator is 0.1-0.5%, and the added amount is 0.05-0.1% of the total volume of the mixed solution.

9. The method for purifying heparin sodium by enzymatic hydrolysis according to claim 4, characterized in that: In the S2.1, the mass concentration of tetramethylethylenediamine is 0.1-0.3%.

10. The method for purifying heparin sodium by enzymatic hydrolysis according to claim 4, characterized in that: In S2.2, the concentration of trypsin in Tris-HCl buffer is 1-10 mg / mL.

Citation Information

Patent Citations

  • Preparation and purification method of heparin hexasaccharides containing N-unsubstituted glucosamine

    CN103724458A

  • Preparation method for heparin sodium

    CN105399867A

  • Extracting method of immobilized enzyme enzymolysis pig small intestine fine heparin sodium

    CN105936652A

  • Heparin sodium wastewater treatment process for highly-efficient recovery of proteins

    CN110217911A

  • Preparation method for protease / polyacrylamide aquagel microsphere catalytic material and application of protease / polyacrylamide aquagel microsphere catalytic material

    CN112980818A

Cited By

  • Enzymolysis preparation method of low-molecular-weight heparin sodium

    CN120026071A